(Q80403161)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17536884%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Renal safety of intravenous ibandronic Acid in breast cancer patients with metastatic bone disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17536884%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1 reference

Nina V Lyubimova

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17536884%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Nikolay E Kushlinsky

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17536884%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Michail R Lichinitser

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17536884%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Karl Schlosser

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17536884%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17536884%20AND%20SRC:MED&resulttype=core&format=json

Clinical Drug Investigation

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17536884%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17536884%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17536884%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

707-716

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17536884%20AND%20SRC:MED&resulttype=core&format=json

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

31 December 2019

cites work

1 reference

12 December 2020

A diagnostic programme for quantitative analysis of proteinuria

1 reference

12 December 2020

Estimation of ifosfamide/cisplatinum-induced renal toxicity by urinary protein analysis

1 reference

12 December 2020

Esophagitis associated with the use of alendronate

1 reference

12 December 2020

Comparative tolerability of drug therapies for hypercalcaemia of malignancy

1 reference

12 December 2020

Effects of intravenous diphosphonates on renal function

1 reference

12 December 2020

Acute intravenous infusion of disodium dihydrogen (1-hydroxyethylidene)diphosphonate: mechanism of toxicity.

1 reference

12 December 2020

Renal failure associated with intravenous diphosphonates

1 reference

12 December 2020

Urinary enzymes, nephrotoxicity and renal disease

1 reference

12 December 2020

Diagnostic strategies in urinalysis

1 reference

12 December 2020

Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia

1 reference

12 December 2020

Consequences of neoplasia induced bone-resorption and the use of clodronate (review).

1 reference

12 December 2020

Treatment of tumor hypercalcemia with clodronate. Effect on parathormone and calcitriol

1 reference

12 December 2020

Comparison of renal function parameters in the assessment of cis-platin induced nephrotoxicity

1 reference

12 December 2020

Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy

1 reference

12 December 2020

Utility of filtration markers to monitor the quality of glomerular function

1 reference

12 December 2020

Pamidronate: an unrecognized problem in gastrointestinal tolerability

1 reference

12 December 2020

Urinary excretion of albumin in normal man: the effect of water loading

1 reference

12 December 2020

Urinary proteins of tubular origin: basic immunochemical and clinical aspects

1 reference

12 December 2020

Administration of the bisphosphonate ibandronate (BM 21.0955) by intravenous bolus injection

1 reference

12 December 2020

Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial

1 reference

12 December 2020

Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.

1 reference

12 December 2020

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer

1 reference

12 December 2020

Urinary enzyme measurements in the diagnosis of renal disorders

1 reference

12 December 2020

BM 21.0955, a potent new bisphosphonate to inhibit bone resorption

1 reference

12 December 2020

Markers for the diagnosis and monitoring of renal tubular lesions

1 reference

12 December 2020

Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate.

1 reference

12 December 2020

10.2165/00044011-200323110-00003

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17536884%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference